Drug R&D
GI-1606
![Foto de Drug R&D](/img/grupo.png)
![Foto de Universitat Pompeu Fabra](/img/noimage_org.png)
Universitat Pompeu Fabra
Barcelona, EspañaPublications in collaboration with researchers from Universitat Pompeu Fabra (8)
2010
-
Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D2and D3 receptors
ChemMedChem, Vol. 5, Núm. 8, pp. 1300-1317
2009
-
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands
Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 6, pp. 1773-1778
2008
-
Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics
Journal of Medicinal Chemistry, Vol. 51, Núm. 19, pp. 6085-6094
2007
-
Multistructure 3D-QSAR studies on a series of conformationally constrained butyrophenones docked into a new homology model of the 5-HT2A receptor
Journal of Medicinal Chemistry, Vol. 50, Núm. 14, pp. 3242-3255
2006
-
QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine
Neuropharmacology, Vol. 51, Núm. 2, pp. 251-262
2003
-
Conformationally constrained butyrophenones as new pharmacological tools to study 5-HT2A and 5-HT2C receptor behaviours
European Journal of Medicinal Chemistry
2002
-
New serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptor antagonists: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones
Journal of Medicinal Chemistry, Vol. 45, Núm. 1, pp. 54-71
1999
-
Conformationally constrained butyrophenones with mixed dopaminergic (D2) and serotoninergic (5-HT2(A), 5-HT2(C)) affinities: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and - thienocycloalkanones as putative atypical antipsychotics
Journal of Medicinal Chemistry, Vol. 42, Núm. 15, pp. 2774-2797